Doximity’s Dip: A Spot of Bother, But Nothing a Good Analyst Can’t Sort

The sales figures, you see, have been slowing down. From a brisk 23% last year to a rather more sedate 10% this quarter. A bit like a promising racehorse losing its steam, what? And this cautious forecast has understandably ruffled a few feathers. To add to the general air of mild panic, net income has dipped from a respectable $75 million to $62 million, thanks to a rather enthusiastic splurge on marketing and a significant investment in their artificial intelligence infrastructure. One can’t have everything, of course, but it does present a bit of a puzzle.








